Researchers find avian virus may be harmful to cancer cells
April 13, 2013
A study at the Virginia-Maryland Regional College of Veterinary Medicine has identified a chicken-killing virus as a promising treatment for prostate cancer in humans.
First genetic factor in prostate cancer prognosis identified
April 13, 2013
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease. This is the main conclusion to come out of a study published this week in the Journal of Clinical Oncology, in which David Olmos, Head of the Prostate Cancer and Genitourinary Tumours Clinical Research Unit at the Spanish National Cancer Research Centre (CNIO), has taken part in, along with Elena Castro, a member of the Unit, and British researchers at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. According to Olmos: “Whilst the majority of patients with prostate cancer have an excellent prognosis, one of the biggest challenges we face in daily clinical practice is the difficulty of identifying those patients in which the illness can be fatal.”
New Prostate Cancer Tests Could Reduce False Alarms
April 13, 2013
Sophisticated new prostate cancer tests are coming to market that might supplement the unreliable P.S.A. test, potentially saving tens of thousands of men each year from unnecessary biopsies, operations and radiation treatments.
Life after prostate cancer improved thanks to better detection and more treatment choices
April 13, 2013
Significant advancements in the detection and treatment of prostate cancer — the second-most common cause of cancer death in men behind lung cancer — means prostate cancer doesn’t have to be a death sentence or the end of your sex life.
Screenings of the prostate, a walnut-sized portion of a man’s reproductive system that wraps around the urethra, the tube that carries urine out of the body, have improved. More information on prevention is available as are considerably more options — from monitoring to surgery with robotics.
Prostate cancer now detectable using imaging-guided biopsy
March 1, 2013
Groundbreaking research by a team of UCLA physicians and engineers demonstrates that prostate cancer — long identifiable only through painful, hit-or-miss biopsies — can be diagnosed far more easily and accurately using a new image-guided, targeted biopsy procedure.
Read the article, which includes a video.
Video: Understanding and implementing immunotherapy for prostate cancer
February 22, 2013
Understanding and implementing immunotherapy for prostate cancer, by Charles G. Drake, MD, PhD of Johns Hopkins Kimmel Cancer Center
A review of emerging strategies for optimizing the clinical impact of immunotherapeutic agents in prostate cancer
February 22, 2013
The potential role of immunotherapy in the clinical management of malignancies has been debated for decades by researchers and medical oncologists. The discussion has been taken to a more practical level with the FDA approval of sipuleucel-T, the first personalized immunotherapy that activates the patient’s own immune cells to target and attack prostate cancer cells.
New prostate cancer test could change treatment.
February 9, 2013
Read more at: http://medicalxpress.com/news/2013-02-prostate-cancer-treatment.html#jCp
PSA Levels Higher in Sedentary Men
January 21, 2013
PSA concentrations are higher in men who engage in more sedentary behavior and lower levels of light physical activity, a study found.
It is hypothesized that regular participation in physical activity may reduce prostate cancer risk through a variety of biological mechanisms including changes in energy balance, immune function, inflammation, antioxidant defenses, and endogenous hormones.
Based on their results, the authors stated, evaluation of a patient’s physical activity and sedentary level before PSA testing also is important because these factors also may influence measurements and lead to a urologic diagnostic workup.
MR-US Fusion Targeted Biopsy Boosts Detection of Prostate Cancer
December 17, 2012
Targeted biopsy of suspected prostate cancer (PCa) lesions, identified using magnetic resonance-ultrasound (MR-US) fusion, increases PCa detection and detects aggressive tumors that may be missed by conventional biopsy, according to a study published in The Journal of Urology (2012;189:86-92).